Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Total 13F shares
-
84,683,348
-
Share change
-
+84,683,348
-
Total reported value
-
$3,603,495,710
-
Price per share
-
$42.59
-
Number of holders
-
94
-
Value change
-
+$3,603,495,710
-
Number of buys
-
94
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q3 2020
As of 30 Sep 2020,
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,683,348 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, TRV GP III, LLC, FMR LLC, Casdin Capital, LLC, BVF INC/IL, EcoR1 Capital, LLC, TRV GP IV, LLC, PERCEPTIVE ADVISORS LLC, Foresite Capital Management IV, LLC, and BlackRock Inc..
This page lists
94
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.